Overview
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
Status:
Completed
Completed
Trial end date:
2010-02-01
2010-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merz Pharmaceuticals GmbH
Criteria
Inclusion Criteria:- Patients aged 18 to 75 years with a clinical diagnosis of first onset,
- Persistent (i.e. tinnitus should never be absent for > 24 hours in a row), subjective,
uni- or bilateral tinnitus present for at least 3 months but not more than 12 months
Exclusion Criteria:
- Clinical diagnosis of intermittent or pulsatile tinnitus
- Patients who have tinnitus as a concomitant symptom of an otological/neurological
disease (such as otitis media, Menière's disease, otosclerosis, etc)